0.384 0 (0%) | 02-17 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 0.81 | 1-year : | 0.95 |
Resists | First : | 0.69 | Second : | 0.81 |
Pivot price | 0.66 | |||
Supports | First : | 0.57 | Second : | 0.5 |
MAs | MA(5) : | 0.66 | MA(20) : | 0.64 |
MA(100) : | 0.42 | MA(250) : | 0.36 | |
MACD | MACD : | 0 | Signal : | 0 |
%K %D | K(14,3) : | 88.3 | D(3) : | 82.2 |
RSI | RSI(14): 61.8 | |||
52-week | High : | 0.69 | Low : | 0.19 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ISR ] has closed below upper band by 25.7%. Bollinger Bands are 32.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 0.69 - 0.7 | 0.7 - 0.7 |
Low: | 0.64 - 0.64 | 0.64 - 0.64 |
Close: | 0.68 - 0.69 | 0.69 - 0.7 |
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
Thu, 14 Mar 2024
IsoRay: Fiscal 2Q Earnings Snapshot - Yahoo Movies Canada
Wed, 08 Feb 2023
Medtech companies merge to form Perspective Therapeutics - Corridor Business
Tue, 07 Feb 2023
Isoray Completes Merger with Viewpoint Molecular - FinSMEs
Mon, 06 Feb 2023
Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted ... - Business Wire
Thu, 20 Oct 2022
Isoray Stock: Not Going Anywhere Anytime Soon (NYSE:ISR) - Seeking Alpha
Tue, 18 Oct 2022
Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 ... - Business Wire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
AMEX
|
|
Sector:
Healthcare
|
|
Industry:
Medical Devices
|
|
Shares Out | 142 (M) |
Shares Float | 140 (M) |
Held by Insiders | 0.8 (%) |
Held by Institutions | 11.2 (%) |
Shares Short | 1,150 (K) |
Shares Short P.Month | 1,580 (K) |
EPS | -0.04 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0.05 |
Book Value (p.s.) | 0.46 |
Profit Margin | -48.1 % |
Operating Margin | -48.9 % |
Return on Assets (ttm) | -8.2 % |
Return on Equity (ttm) | -13.9 % |
Qtrly Rev. Growth | 7.5 % |
Gross Profit (p.s.) | 0.03 |
Sales Per Share | 0.07 |
EBITDA (p.s.) | -0.04 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -5 (M) |
Levered Free Cash Flow | -3 (M) |
PE Ratio | -17.25 |
PEG Ratio | 0 |
Price to Book value | 1.49 |
Price to Sales | 9.56 |
Price to Cash Flow | -21.38 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |